Cribstone Capital Management, LLC Crispr Therapeutics Ag Transaction History

Cribstone Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 18, 2021	SELL	$110.2 - $156.64 $8,265 - $11,747	-75 Closed	0 $0
Q4 2019 Jan 08, 2020	SELL	$36.68 - $73.13 $4,071 - $8,117	-111 Reduced 59.68%	75 $5,000
Q3 2018 Oct 25, 2018	BUY	$44.35 - $65.71 $3,326 - $4,928	75 Added 67.57%	186 $8,000
Q1 2018 Apr 19, 2018	BUY	$23.52 - $58.17 $493 - $1,221	21 Added 23.33%	111 $5,000
Q3 2017 Oct 30, 2017	BUY	$16.75 - $20.66 $1,507 - $1,859	90	90 $2,000

488

64.1M

1.64M

1.93M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.2B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Cribstone Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cribstone Capital Management, LLC with notifications on news.